Skip to navigation

Press Releases

2011 Press Releases

Date       Title
November 21, 2011       MEDWELL CAPITAL COMPLETES ADOPTION OF IFRS
November 21, 2011       MEDWELL CAPITAL REPORTS THIRD QUARTER 2011 RESULTS
October 18, 2011       MEDWELL CAPITAL CORP. COMPLETES $2 MILLION INVESTMENT IN MIMETOGEN PHARMACEUTICALS INC.
October 3, 2011       MEDWELL CAPITAL TO ADOPT IFRS
September 9, 2011       MEDWELL CAPITAL AND SPECTRAL DIAGNOSTICS ANNOUNCE COMPLETION OF PLAN OF ARRANGEMENT
August 30, 2011       MEDWELL CAPITAL REPORTS SECOND QUARTER 2011 RESULTS
August 29, 2011       MEDWELL CAPITAL AND SPECTRAL DIAGNOSTICS ANNOUNCE COURT APPROVAL OF PLAN OF ARRANGEMENT AND SET CLOSING AND RECORD DATE FOR COMPLETION
August 26, 2011       MEDWELL ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT
August 17, 2011       TWO LEADING INDEPENDENT ADVISORY SERVICES RECOMMEND THAT MEDWELL SHAREHOLDERS VOTE FOR ALL PROPOSED RESOLUTIONS
July 15, 2011       MEDWELL GRANTED INTERIM COURT ORDER IN RESPECT OF PLAN OF ARRANGEMENT
June 28, 2011       MEDWELL CAPITAL AND SPECTRAL DIAGNOSTICS ANNOUNCE PLAN OF ARRANGEMENT
June 27, 2011       Mimetogen Pharmaceutical Inc. Announces Positive Top Line Data from Phase II Clinical Trial of MIM-D3 for Dry Eye Disease
May 30, 2011       MEDWELL CAPITAL REPORTS FIRST QUARTER 2011 RESULTS
April 8, 2011       Medwell Capital Announces that Mimetogen Pharmaceutical Inc. Completes Patient Recruitment in Phase II Clinical Trial for Dry Eye Disease
March 29, 2011       Advisory Contract between Medwell Capital and Spectral Diagnostics Increases
March 28, 2011       MEDWELL CAPITAL AND A CONSORTIUM OF BUYERS ACQUIRE SPECTRAL DIAGNOSTICS SHARES FROM GROWTHWORKS CANADIAN FUND
February 25, 2011       MEDWELL CAPITAL ANNOUNCES $2 MILLION INVESTMENT IN MIMETOGEN PHARMACEUTICALS
February 11, 2011       MEDWELL CAPITAL REPORTS 2010 YEAR-END RESULTS

Current News